The Japanese Patent Office has announced that it has decided to grant BrainCool's technology to detect shivering for the product BrainCool ™ System patent approval in Japan.

BrainCool AB (publ) (together with its subsidiary BrainCool Inc.), an innovative Swedish medical device company with focus on temperature management today announced two management changes.

BrainCool Ab (publ) Completes Patient Recruitment in a Scandinavian Pivotal Trial for FDA Clearance of Oral Mucositis Treatment in the United States. Intra-Oral Cooling Device is Tested in 180 Patients to Eliminate Oral Mucositis (OM), One of the Severest Side-Effects of Radiology and Chemotherapy for Blood, Bone or Solid Tumor Cancer Treatment

BrainCool Inc is led by VP Bryan Nicholson with the objective to launch BrainCool’s first product on the US market - the IQool™ System.

BrainCool Commended by Frost & Sullivan for the North American Launch of its IQool™ System, a Next-Generation Patient Cooling Medical Device

BrainCool AB (publ) (”BrainCool”) has signed an agreement relating to an investment of up to SEK 100 million.